Actively Recruiting
A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Cystic Fibrosis (CF-CHINA)
Led by Peking Union Medical College Hospital · Updated on 2022-03-21
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Cystic fibrosis (CF) is a rare inherited disease that affects multiple organs, especially the lungs and digestive system. It is most commonly observed in Caucasians, but few cases have been reported among the large Chinese population. This research aims to accurately assess the prevalence of CF in China, along with the disease status, diagnosis and treatment approaches, quality of care, and health-related outcomes for Chinese patients. This study is observational and does not involve experimental treatments or interventions. It collects clinical information about Chinese patients diagnosed with CF, following the World Health Organization's diagnostic criteria. The study will monitor these patients over time to understand their lung function and related health measures. Participants will be evaluated for lung health changes, including spirometry tests measuring FEV1 and FVC, over a 10-year period. Data on genetics, clinical symptoms, treatments, and outcomes will be gathered to provide a comprehensive view of CF in China. Informed consent is required, and patients must be stable without recent respiratory infections to participate.
CONDITIONS
Brief Title
A National Registry on Chinese Patients With Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfilled WHO clinical diagnostic criteria for cystic fibrosis
- In a stable phase with no respiratory infections for nearly 4 weeks
- Subjects or their guardians signed informed consent
You will not qualify if you...
- Patients with other bronchiectasis who do not meet inclusion criteria
- Those with severe cardiac disease
- Those with severe renal disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed over time to collect data on clinical manifestations, genetics, interventions, and outcomes related to cystic fibrosis.
Regular follow-up visits as determined by the registry
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
X
Xinlun Tian, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here